Due to an ongoing shortage of ADHD medications, the U.S. Food and Drug Administration (FDA) has approved several generic versions of the drug Vyvanse for the treatment of attention-deficit/hyperactivity disorder. New studies show that the number of people being diagnosed with ADHD is climbing steadily, especially in women. FOX's Eben Brown speaks with Dr. Marc Siegel, Professor Of Medicine at NYU Langone Medical Center and FOX News Medical Contributor, about the supply impact of the FDA's decision and the rise in the number of those diagnosed with ADHD. 

Click Here To Follow 'The FOX News Rundown: Evening Edition'
Learn more about your ad choices. Visit megaphone.fm/adchoices